Year: 2018
Type: dissertation
Study design: Observational Study
Abstract: This thesis focused on different aspects of melanoma treatment with immunotherapy and targeted therapy. In chapter 2 we search for biomarkers that could be associated with overall survival in patients treated with ipilimumab. In chapter 3 we describe diarrea, a commonly seen side effect of immunotherapy. Here we show that there is no significant correlation between grade of diarrhea and severity of colitis as seen during endoscopy. Chapters 4 and 5 describe patients with brain metastases and/or leptomeningeal metastases. In chapter 4 we show the difference in overall survival in patients treated with vemurafenib, dabrafenib or the combination of dabrafenib + trametinib. Chapter 5 focusses on the treatment of leptomeningeal metastases. Here a significant difference in overall survival was noted between treated and untreated patients. Furthermore LDH was a predictive biomarker for overall survival. In chapter 6 we show that treating patients with vemurafenib beyond progression of disease has a significant impact on overall survival. Lastly in chapter 7 we review the past, present and future of treating patients with different kinds of cancer with tumor-infiltrating lymphocytes.
Author: Geukes Foppen, M.H.
Institution: Leiden University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: advanced melanoma, immunotherapy, targeted therapy, ipilimumab, biomarkers, diarrhea, colitis, brain metastases, leptomeningeal metastasis, vemurafenib, dabrafenib, trametinib, overall survival, lactate dehydrogenase, predictive biomarkers, tumor-infiltrating lymphocytes, maintenance therapy
Open Access status: green
OpenAlex ID: W6999124651
